Two inflammatory tear fluid biomarkers may serve a diagnostic purpose in thyroid eye disease, according to a cross-sectional study.

There was a lot of excitement when Tepezza became the first drug approved for the treatment of thyroid eye disease in January ...

Recent acquisitions include the SONOPET, an ultrasonic device that can aid in surgery for thyroid eye disease as well as safe removal of eye tumors. "This device gives us even greater precision for ...

After a while, LaQuilla Harris says her left eye traveled up into her head, and she could no longer see it, so she started wearing an eye patch.

What is Graves’ disease? Graves’ disease—which affects about 1% of people in the U.S.—is an autoimmune disorder that occurs when the thyroid gland produces too much thyroid hormone.

2 Eyesthetica, Oculofacial and Cosmetic Surgery Associates, Los Angeles, CA, United States We report a case of thyroid eye disease (TED) reactivation, review the literature, and raise awareness of ...

The U.S. Food and Drug Administration has approved the first-in-class TRPM8 receptor agonist Tryptyr (acoltremon ophthalmic solution) for the treatment of signs and symptoms of dry eye disease ...

Thyroid eye disease is often misunderstood, and many myths about the prognosis, symptoms, and treatment persist. Myths about the chronic condition include the misconception that TED develops only ...

Although there’s no cure for thyroid eye disease (TED), effective treatments and lifestyle changes can help you manage symptoms, such as double vision, eye pain, and dry, irritated eyes. These ...

The FDA has approved Tryptyr (acoltremon) as the first TRPM8-targeting eye drop for dry eye disease, stimulating natural tear production as early as day one.